…
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
| Income before tax | -5.37M | -6.93M | -3.73M | -2.89M | -2.58M |
| Net income | -5.37M | -6.93M | -3.73M | -2.89M | -2.58M |
| Selling general administrative | 1.89M | 3.96M | 5.30M | 4.28M | 1.73M |
| Gross profit | 0.41M | 1.19M | 2.19M | 2.28M | 0.00M |
| Reconciled depreciation | 0.00M | 0.00M | 0.15M | 0.15M | 0.07M |
| Ebit | - | -2.92M | -3.26M | -2.01M | -1.80M |
| Ebitda | -4.61M | -6.36M | -3.18M | -1.95M | -2.48M |
| Operating income | -1.48M | -2.77M | -3.26M | -2.15M | -1.80M |
| Other operating expenses | - | - | - | - | 0.06M |
| Interest expense | 0.75M | 0.57M | 0.40M | 0.00M | 0.00M |
| Interest income | - | - | - | - | 0.00M |
| Net interest income | -0.75M | -0.57M | -0.46M | -0.86M | -0.03M |
| Non recurring | - | - | - | - | 0.58M |
| Income tax expense | - | - | - | 0.00M | 0.00M |
| Total revenue | 0.91M | 2.97M | 4.05M | 4.15M | 0.00M |
| Total operating expenses | 2.39M | 5.75M | 7.31M | 6.30M | 1.80M |
| Cost of revenue | 0.50M | 1.78M | 1.86M | 1.87M | 0.00M |
| Total other income expense net | -3.14M | -3.59M | -0.01M | 0.11M | -0.75M |
| Net income from continuing ops | -5.37M | -6.93M | -3.73M | -2.89M | -2.58M |
| Net income applicable to common shares | - | -6.93M | -3.73M | -2.89M | -2.58M |
| Breakdown | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
| Total assets | 0.76M | 4.33M | 8.56M | 8.58M | 7.12M |
| Intangible assets | 0.57M | 3.32M | 4.47M | 3.46M | 0.00M |
| Other current assets | - | - | 0.07M | - | 0.00M |
| Total liab | 5.66M | 4.07M | 3.51M | 3.47M | 4.79M |
| Total stockholder equity | -4.90M | 0.27M | 5.05M | 5.11M | 2.32M |
| Other current liab | - | 0.24M | - | 0.15M | 0.65M |
| Common stock | - | 14.07M | 13.37M | 10.74M | 5.18M |
| Capital stock | 14.18M | 14.07M | 13.37M | - | - |
| Retained earnings | -23.82M | -18.45M | -11.52M | -7.69M | -4.79M |
| Other liab | - | 0.08M | 0.20M | 0.11M | - |
| Good will | 0.00M | 0.21M | 2.28M | 2.28M | - |
| Other assets | - | - | - | - | 6.08M |
| Cash | 0.06M | 0.19M | 0.88M | 2.08M | 0.90M |
| Total current liabilities | 5.61M | 4.20M | 1.34M | 3.36M | 1.29M |
| Net debt | 3.13M | 2.62M | 1.87M | 0.79M | - |
| Short term debt | - | - | 0.77M | 2.86M | 0.03M |
| Short long term debt | 3.20M | 2.81M | 0.77M | 2.86M | 0.03M |
| Other stockholder equity | - | 3.02M | 1.78M | 0.76M | 1.70M |
| Property plant equipment | - | 0.01M | 0.01M | 0.02M | - |
| Total current assets | 0.18M | 0.79M | 1.80M | 2.83M | 1.04M |
| Net tangible assets | - | -3.48M | -1.70M | -0.62M | 2.32M |
| Short term investments | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Net receivables | 0.17M | 0.38M | 0.16M | 0.14M | 0.12M |
| Long term debt | - | - | 1.97M | - | 3.50M |
| Inventory | 0.04M | 0.13M | 0.56M | 0.35M | 0.00M |
| Accounts payable | - | 1.39M | 0.57M | 0.35M | 0.61M |
| Non currrent assets other | - | - | 6.76M | 5.75M | 6.08M |
| Non current assets total | 0.58M | 3.54M | 6.76M | 5.75M | 6.08M |
| Breakdown | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
| Investments | 0.00M | -0.28M | -0.35M | -0.31M | -2.56M |
| Change to liabilities | - | 0.82M | 0.22M | -0.26M | 0.21M |
| Total cashflows from investing activities | - | -0.28M | -0.35M | -0.31M | -2.54M |
| Net borrowings | - | -0.16M | 1.01M | 1.34M | 2.10M |
| Total cash from financing activities | -0.00M | 1.76M | 2.36M | 3.84M | 4.69M |
| Change to operating activities | - | 0.04M | 0.13M | -0.25M | 0.02M |
| Net income | -5.37M | -6.93M | -3.73M | -2.89M | -2.58M |
| Change in cash | -0.13M | -0.68M | -1.20M | 1.17M | 0.86M |
| Begin period cash flow | 0.19M | 0.88M | 2.08M | 0.90M | 0.05M |
| End period cash flow | 0.06M | 0.19M | 0.88M | 2.08M | 0.90M |
| Total cash from operating activities | -0.13M | -2.16M | -3.21M | -2.36M | -1.29M |
| Issuance of capital stock | 0.09M | 0.40M | 1.18M | - | - |
| Depreciation | 0.00M | 0.00M | 0.15M | 0.15M | 0.07M |
| Other cashflows from investing activities | - | -0.27M | -0.07M | -0.07M | -0.07M |
| Change to inventory | 0.09M | 0.43M | -0.22M | -0.15M | 0.02M |
| Change to account receivables | - | -0.37M | -0.02M | -0.02M | -0.03M |
| Sale purchase of stock | - | - | - | - | 1.50M |
| Other cashflows from financing activities | - | 1.45M | 0.36M | 0.36M | 1.09M |
| Change to netincome | - | 3.85M | 0.19M | 1.01M | 1.01M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.02M | 0.02M |
| Change in working capital | 1.51M | 0.92M | 0.12M | -0.68M | 0.22M |
| Stock based compensation | 0.05M | 0.03M | 0.03M | - | - |
| Other non cash items | 0.69M | 0.57M | 0.15M | 0.36M | 0.22M |
| Free cash flow | -0.13M | -2.17M | -3.42M | -2.45M | -1.29M |
Sector: Healthcare Industry: Pharmaceutical Retailers
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HITI High Tide Inc |
0.13 3.41% |
3.94 | - | 45.05 | 0.46 | 3.36 | 0.65 | 10.91 |
| PCRX PharmaCorp Rx Inc. |
-0.01 1.22% |
0.41 | 20.50 | 41.49 | 2.78 | 1.65 | 2.77 | 41.56 |
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.
1000 Sherbrooke Street West, Montreal, QC, Canada, H3A 3G4
888 528 8687
| Name | Title | Year Born |
|---|---|---|
| Mr. Aurelio Useche C.M.A., M.B.A. | Pres, CEO & Director | 1968 |
| Mr. Mark Anthony Billings C.F.A., CFA, M.B.A., MBA | Chief Financial Officer | 1970 |
| Mr. Edward Ierfino B. Comm. | Mang. of Investor Relations | 1968 |
| Mr. Abis Hussain | Sr. Marketing Officer | NA |
| Mr. David A. Johnson | Corp. Sec. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.